These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10617182)

  • 21. Patent office decisions strengthened by Supreme Court.
    Baggot BX
    Nat Biotechnol; 1999 Nov; 17(11):1131-2. PubMed ID: 10545924
    [No Abstract]   [Full Text] [Related]  

  • 22. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond the letter of the law: the US Federal Circuit interprets section 271(g)(1).
    Tsao R; Hurley EA
    Nat Biotechnol; 1997 Jan; 15(1):86-7. PubMed ID: 9035112
    [No Abstract]   [Full Text] [Related]  

  • 24. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 25. Australia annuls Roche's native Taq patent.
    Dickson D
    Nature; 1997 Nov; 390(6658):327. PubMed ID: 9389463
    [No Abstract]   [Full Text] [Related]  

  • 26. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 27. US companies settle EPO patent suit.
    Gershon D
    Nature; 1993 May; 363(6426):196. PubMed ID: 8487853
    [No Abstract]   [Full Text] [Related]  

  • 28. US court case to define EST patentability.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract]   [Full Text] [Related]  

  • 29. Super-enzyme patents get their day in court.
    Cyranoski D
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent US patent legislation: what's new for biotech?
    Gogoris AC; Todaro JC
    Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intellectual property. Biotech feels a chill from changing U.S. patent rules.
    Servick K
    Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626
    [No Abstract]   [Full Text] [Related]  

  • 32. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 33. Patents. U.S. Supreme Court delves into what is and isn't patentable.
    Marshall E
    Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
    [No Abstract]   [Full Text] [Related]  

  • 34. Opinions evolve on Kauffman patent.
    Dove A
    Nat Biotechnol; 2000 Apr; 18(4):373. PubMed ID: 10748506
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 36. US acts to lengthen term of patents to help biotechnology.
    Wadman M
    Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotech patents: looking backward while moving forward.
    Eisenberg RS
    Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
    [No Abstract]   [Full Text] [Related]  

  • 38. Patent office resurrects EST debate.
    Chahine K
    Nat Biotechnol; 1998 Aug; 16(8):711. PubMed ID: 9702759
    [No Abstract]   [Full Text] [Related]  

  • 39. Patent protection for Aspergillus-related inventions.
    Jong SC; Birmingham JM
    Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process patent bill on track.
    Gershon D
    Nature; 1993 Jul; 364(6435):274. PubMed ID: 8332176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.